Status:
RECRUITING
Evaluating the Implementation and Impact of Navigator-delivered ePRO System
Lead Sponsor:
University of Alabama at Birmingham
Collaborating Sponsors:
University of South Alabama
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
1\) Evaluate implementation of navigator-delivered Home ePRO for all cancer patients across multiple practice sites; 2) examine the barriers, facilitators, and implementation strategies used in implem...
Detailed Description
Randomized controlled trials by Basch (collaborator) and colleagues demonstrated that weekly electronic home-based PRO symptom monitoring with automated alerts to clinicians (Home ePRO) in cancer pati...
Eligibility Criteria
Inclusion
- Patient Group:
- Age ≥18
- Cancer patients at participating institution
- Receipt of chemotherapy, targeted therapy, and immunotherapy at participating institution from 2019-2026.
Exclusion
- \- Second opinion only at participating institution.
Key Trial Info
Start Date :
May 4 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2027
Estimated Enrollment :
7500 Patients enrolled
Trial Details
Trial ID
NCT04809740
Start Date
May 4 2021
End Date
January 1 2027
Last Update
May 21 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35249
2
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35249